Literature DB >> 16540914

Antimeasles immunoglobulin g for serologic diagnosis of otosclerotic hearing loss.

Tamás Karosi1, József Kónya, Mihály Petkó, László Z Szabó, József Pytel, József Jóri, István Sziklai.   

Abstract

HYPOTHESIS: Persistent measles virus infection of the otic capsule is suggested to be an etiologic factor in otosclerosis. Otosclerosis is a disease of complex unknown etiology causing progressive conductive and/or sensorineural hearing loss (HL).
BACKGROUND: Diagnostic methods of otosclerosis are sensitive to ossicular chain fixation with low specificity for otosclerotic stapes ankylosis.
METHODS: Nucleic acid was extracted from stapes foot plates of clinically stapes fixation patients (N = 213). Measles virus nucleoprotein RNA was amplified by reverse-transcriptase polymerase chain reaction. Amplification results were correlated to histologic findings in 49 cases. Antimeasles IgG levels of all clinically stapes fixation as well as control sera specimens were measured by enzyme-linked immunosorbent assay.
RESULTS: Among clinically stapes fixation patients, 141 stapes foot plates contained measles virus RNA. Among 49 histologic specimens, viral RNA was detectable only in histologically otosclerotic stapes foot plates (n = 35). Histology for virus-negative foot plates (n = 14) excluded otosclerosis. Antimeasles IgG levels were significantly lower in the sera of patients with virus-positive stapes than in control sera.
CONCLUSIONS: Combination of decreased antimeasles IgG serum level and conductive HL has a great specificity and sensitivity as a diagnostic method in the preoperative evaluation of ossicular chain fixations otosclerosis. Low antimeasles IgG level indicates otosclerosis, whereas high level suggests non-otosclerotic ossicular chain fixations. Preoperative elucidation of the cause of a conductive HL may suggest optional medical treatment in preference to surgical methods.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540914     DOI: 10.1097/01.mlg.0000204142.80263.2b

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  Etiopathogenesis of otosclerosis.

Authors:  Tamás Karosi; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

2.  No evidence for an association between persistent measles virus infection and otosclerosis among patients with otosclerosis in Japan.

Authors:  Noritaka Komune; Mitsuru Ohashi; Nozomu Matsumoto; Takashi Kimitsuki; Shizuo Komune; Yusuke Yanagi
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  The influence of measles vaccination on the incidence of otosclerosis in Germany.

Authors:  Wolfgang Arnold; Raymonde Busch; Andreas Arnold; Björn Ritscher; Albrecht Neiss; Hans Peter Niedermeyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-13       Impact factor: 2.503

Review 4.  Perspectives of pharmacological treatment in otosclerosis.

Authors:  Balázs Liktor; Zoltán Szekanecz; Tamás József Batta; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

Review 5.  An overview of the etiology of otosclerosis.

Authors:  Konstantinos Markou; John Goudakos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-13       Impact factor: 2.503

6.  Otosclerosis: an organ-specific inflammatory disease with sensorineural hearing loss.

Authors:  István Sziklai; Tamás József Batta; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

7.  Expression of measles virus receptors in otosclerotic, non-otosclerotic and in normal stapes footplates.

Authors:  Tamás Karosi; István Jókay; József Kónya; Mihály Petkó; László Z Szabó; István Sziklai
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-09       Impact factor: 3.236

8.  Detection of otosclerosis-specific measles virus receptor (cd46) protein isoforms.

Authors:  Balázs Liktor; Péter Csomor; Tamás Karosi
Journal:  ISRN Otolaryngol       Date:  2013-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.